0

You are referred a 15-year-old boy with stricturing Crohn’s disease that is limited to the small intestine. He was initially treated with infliximab with moderate improvement in his symptoms. What is your best recommendation to monitor his disease activity?

There's more to see -- the rest of this topic is available only to subscribers.